Cancel

Analyst coverage & consensus

Check the latest analyst estimates by VARA Research

Disclaimer

Any opinions, forecasts, estimates, projections, or predictions regarding dsm-firmenich’s performance made by the analysts are theirs alone and do not represent the opinions, forecasts, estimates, projections, or predictions of dsm-firmenich or its management. By providing the names of the analysts, dsm-firmenich does not imply its endorsement of or concurrence with their reports, conclusions, or recommendations. dsm-firmenich assumes no liability for the accuracy of the information provided by analysts and undertakes no obligation to update this information.

Analyst coverage

A wide range of sell-side analysts provide coverage of dsm-firmenich for their clients and the broader market.

Sell-side analyst coverage
InstitutionAnalyst
ABN AMROStefano Toffano
Bank of America Merrill LynchMatthew Yates
BarclaysAlex Sloane
Berenberg BankSebastian Bray
CitigroupSebastian Satz
Davy ResearchCathal Kenny
Deutsche BankVirginie Boucher-Ferte
EquitaMassimo Bonisoli
Exane BNP ParibasNicola Tang
Goldman SachsGeorgina Fraser
INGReg Watson
JefferiesChris Counihan
JP MorganChetan Udeshi
KBC SecuritiesWim Hoste
Kepler ChevreuxMartin Rödiger
Morgan StanleyLisa De Neve
DeGroof PetercamFernand de Boer
Rothschild & Co RedburnArtem Chubarov
UBSCharles Eden
Van Lanschot Kempen Eric Wilmer

Disclaimer
Any opinions, forecasts, estimates, projections, or predictions regarding dsm-firmenich’s performance made by the analysts are theirs alone and do not represent the opinions, forecasts, estimates, projections, or predictions of dsm-firmenich or its management. By providing the names of the analysts, dsm-firmenich does not imply its endorsement of or concurrence with their reports, conclusions, or recommendations. dsm-firmenich assumes no liability for the accuracy of the information provided by analysts and undertakes no obligation to update this information.

Consensus figures per March 2, 2026

The most recent consensus figures provided by Vara Research are detailed below. The figures are based on the estimates given by the banks that were approached.

 FY 2024Q1 2025Q4 2025FY 2025Q1 2026 EFY 2026 E
 Continuing Operations Only
dsm-firmenich, total sales9.0542.3402.1539.0342.2709.170
       
P&B3.7769749043.7609583.811
TTH3.1098277303.1468033.172
HNC2.1175335122.1025112.107
Corporate526726729
       
dsm-firmenich, total organic sales growth in %65231,83,1
       
P&B, organic sales growth in %73433,03,3
TTH, organic sales growth in %107241,52,8
HNC, organic sales growth in %06-130,82,5
       
dsm-firmenich, total Adj. EBITDA margin19,319,719,019,619,319,6
       
P&B, Adj. EBITDA margin22,322,520,221,721,821,6
TTH, Adj. EBITDA margin20,120,620,320,620,320,8
HNC, Adj. EBITDA margin17,818,219,719,419,219,6
       
dsm-firmenich, total Adj. EBITDA1.7514604081.7724391.797
       
P&B, Adj. EBITDA842219183815209823
TTH, Adj. EBITDA626170148648163659
HNC, Adj. EBITDA3779710140798412
Corporate, Adj. EBITDA-94-26-24-98-25-96
       
Adj. EBIT816--861-865
       
Core adj. EBIT1.277--1.290-1.276
       
Core adj. net profit976--887-893
       
Core adj. EPS3,54--3,31-3,49
       
Adjusted Gross Operating Free Cash Flow (€ m) 1.217--950-1.037
       
Adjusted Gross Operating Free Cash Flow/Sales13,4--10,5-11,4
       
Net debt3.306--3.301-3.027
       
     --
What is your expected FX effect in million EUR on total EBITDA?       
  - Consensus-0-30-65-29-58

Disclaimer
Any opinions, forecasts, estimates, projections, or predictions regarding dsm-firmenich’s performance made by the analysts are theirs alone and do not represent the opinions, forecasts, estimates, projections, or predictions of dsm-firmenich or its management. By providing the names of the analysts, dsm-firmenich does not imply its endorsement of or concurrence with their reports, conclusions, or recommendations. dsm-firmenich assumes no liability for the accuracy of the information provided by analysts and undertakes no obligation to update this information.

Contact Investor Relations

Whether you’re a shareholder, potential shareholder, or analyst, our Investor relations team is on hand to answer your questions.

Get in touch
Explore more

  • Results center

    All the key financial performance information published dsm-firmenich

    Read more

  • Financial results & presentations

    All the key financial performance information published dsm-firmenich

    Read more

  • Financial calendar

    A handy overview of the key dates in our financial calendar.

    Read more

Stay up to date

Be the first to know about key news as we continue shaping the future and bringing progress to life.

Subscribe to our newsletter